Currently, an active area of research focuses on finding effective IPMN malignancy predictors, ranging from tumor markers as CA19-9 and CEA to serum inflammatory parameters such as NLR, PLR, and CAR. This evidence concerns the gene CEACAM5 and neoplasm.